| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.096 | 0.06 |